Fayez Sarofim & Co’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262M | Buy |
3,745,902
+2,376,032
| +173% | +$166M | 0.63% | 44 |
|
|
2025
Q1 | $272M | Sell |
1,369,870
-2,273,140
| -62% | -$452M | 0.68% | 43 |
|
|
2024
Q4 | $239M | Buy |
3,643,010
+198,977
| +6% | +$13M | 0.58% | 48 |
|
|
2024
Q3 | $268M | Buy |
3,444,033
+204,858
| +6% | +$16M | 0.68% | 43 |
|
|
2024
Q2 | $253M | Buy |
3,239,175
+248,941
| +8% | +$19.4M | 0.68% | 43 |
|
|
2024
Q1 | $203M | Buy |
2,990,234
+134,784
| +5% | +$9.13M | 0.6% | 48 |
|
|
2023
Q4 | $178M | Buy |
2,855,450
+747,234
| +35% | +$46.5M | 0.54% | 49 |
|
|
2023
Q3 | $143M | Buy |
2,108,216
+560,934
| +36% | +$38M | 0.48% | 54 |
|
|
2023
Q2 | $111M | Buy |
1,547,282
+514,755
| +50% | +$36.8M | 0.39% | 56 |
|
|
2023
Q1 | $71.7M | Buy |
1,032,527
+1,007,832
| +4,081% | +$70M | 0.25% | 62 |
|
|
2022
Q4 | $1.67M | Buy |
+24,695
| New | +$1.67M | 0.01% | 151 |
|
|
2022
Q3 | – | Sell |
-3,345
| Closed | -$221K | – | 279 |
|
|
2022
Q2 | $221K | Buy |
+3,345
| New | +$221K | ﹤0.01% | 282 |
|